Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Digital RESI June Pitch Finalists

26 May

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Congratulations to the Digital RESI June Innovator’s Pitch Challenge (IPC) finalists! Applications came in from companies representing various sectors: therapeutics, medical devices, diagnostics, digital health, and R&D services. These companies will present at the upcoming conference and will each have a dedicated landing page showcasing their product and technology. Each finalist is assigned to a live Q&A session featuring a panel of investors and industry experts who actively seek to work and partner with early-stage innovations.

Companies participating in the IPC have constantly received positive feedback from our investor network due to their high quality of presentation and ability to answer high-level questions, among other positive elements. These sessions have been valuable for the participating companies in being able to connect with relevant investors, and we look forward to another great round of presentations and engaging Q&A from this group. Learn more about each finalist below.

Are you interested in showcasing your startup to early-stage investors at RESI Boston, September 21-22? Contact our business development team to discuss the IPC format and to see if you are a fit!

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Alex
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Alexander Vassallo
Manager of Business Development
Book a Meeting
Email Me

The Faces of Digital RESI June

26 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

Funding in early-stage life science and healthcare has been booming throughout the Covid-19 pandemic, but as we face inflation and a potential economic downturn, the future is not as clear. RESI is much more than a partnering conference in that it also offers value and insight from experts in a variety of formats, one such being panels. RESI panels are primarily run by investors discussing the latest trends and forecasting for specific investment types or sub-sectors. Additionally, RESI offers Tales from the Road panels, which are informal discussions from early-stage entrepreneurs about their fundraising journeys, offering advice and sharing experiences.

Check out the latest panelist lineup from Digital RESI, June 7-9. Sign up to hear from each speaker on their outlooks and best practices while navigating partnerships, deals, and building strong startups.

Tuesday, June 7

11 AM EDT – Beyond Big Pharma
Partnering & Perspectives from Small & Mid-Sized Biotech

Kevin Lin
Director, Business Development
Transcenta Holding		 Sa’ar Yaniv
Director, Business Development
Fortress Biotech		 Rachel Zolot Schwartz, MBA (Moderator)
Vice President & Head, Business Development & Commercial, Volastra

1 PM EDT – Angel Investors
Explaining the Process of Engagement

Ozan Isinak, MBA
President, Central Canada
Keiretsu Forum		 Kristin King
Member
Boston Harbor Angels		 Yaniv Sneor
Founding Member
Mid Atlantic Bio Angels
Eran Steinberg
President & Chairman
Vaica		 Tom Vogelsong, PhD
Director, Deal Flow
KYTO Technology & Life Science

2 PM EDT – The Neuroscience of Aging
Aging Impact on the Nervous System

Mylea Charvat
Founder & CEO
Savonix		 James Mayer
Senior Manager, Investment & Venture Services
Centre for Aging & Brain Health Innovation (CABHI)		 Diana Saraceni
Founder & Managing Partner
Panakes Partners
Lu Zhang
Founder & Managing Partner
Fusion Fund

4 PM EDT – Tales from the Road: AI Innovation in Healthcare
Standing Out in a Growing Field

Kaitlin Christine
Founder & CEO
Gabbi		 Rory McCann (Moderator)
Conference Producer
Life Science Nation		 Maria Luisa Pineda, PhD
Founder & CEO
Envisagenics
Vangelis Vergetis, PhD
Co-Founder & Executive Director
Intelligencia

Wednesday, June 8

11 AM EDT – AI vs. Life Science
Which Comes First in Early-Stage Investment?

Ming Cheah, PhD
Principal
Pivotal bioVenture Partners		 Marina Cortes
Venture Partner
SandBanks Capital		 Baudouin Hue
Partner
Karista
Bill Kuziel (Moderator)
Analyst & Investor
MedPro Investors

1 PM EDT – Corporate VC
The Changing Landscape & New Opportunities

Michael Baran
Executive Director, WRD & Principal
Pfizer Ventures		 Lana Ghanem
Managing Director
Hikma Ventures		 David Gordon
Head, Investments
Longliv Ventures
Jane Rho
Investor
DaVita Venture Group		 Cheryl Zimberlin
Investment Director
M Ventures

2 PM EDT – Asia Cross-Border
Building Global Partnerships

Tai Harada
Vice President
Fast Track Initiative		 Seo Lee
Director
SV Investment		 Cindy Liu
Vice President
Qiming Venture Partners
Derek Yuan
Principal
LYFE Capital

4 PM EDT – Tales from the Road: Age-Related Diseases
Developing Prevention & Treatments

Anthony DePasqua
President
EnClear Therapeutics		 Robin Mansukhani
CEO
Deciduous Therapeutics		 Eric Levitan
 Founder & CEO
Vivo

Thursday, June 9

11 AM EDT – Age-Tech Care Management
Technology Improving the Lives of Older Adults

Anastasiya Giarletta
Principal
R42 Group		 Sarah Hippert
Program Manager
Techstars		 Brenda Hogan (Moderator)
Chief Investment Officer
Ontario Capital Growth Corporation (OCGC)
Lise Pape
Founder
Walk with Path

1 PM EDT – Impact Investors
More Than Financial Returns

André Harrell
Venture Partner
Cancer Fund		 Richard Lipkin
Co-Founder & Co-Chair
The Catalytic Impact Foundation		 Ben Nahir
Venture Principal
Elevate Capital
John Parker (Moderator)
Founder & Managing Director
Springhood Impact Ventures

2 PM EDT – Team, Tech, & Traction in Early-Stage AI
Building Your Startup as a Triple Threat

Sebastien Latapie
Principal
Dynamk Capital		 Gayathri Radhakrishnan, MBA
Senior Director Venture Capital – AI Fund
Micron Ventures		 Surbhi Sarna
Group Partner
Y Combinator
Alex Zhavoronkov, PhD (Moderator)
CEO
InSilico Medicine

3 PM EDT – Software-Enabled Medical Devices
Investing at the Intersection of Digital Health and Medtech

Chris Bostick
Partner
OCV Partners		 Lana Caron
Innovation Lead
Philips Health Technology Ventures		 James Hardiman
Partner
Data Collective (DCVC Bio)
Katherine Relle, MBA
Vice President
Accelmed

4 PM EDT – Tales from the Road: Biotech and MedTech Innovators
Entrepreneurs on Their Fundraising Journey

Sven Henrichwark, PhD
CEO
Fibronostics		 David Sherris, PhD
CEO
Penrose TherapeuTx

Care in Space

26 May

By Alexander Vassallo, Manager of Business Development West Coast (US), LSN

For innovative startups in life science and healthcare, the early days feel like the sky is the limit. But what if it wasn’t? Care in Space is a newly launched initiative supporting the development and commercialization of technologies and solutions that will support long-term habitation and travel in space and/or utilize microgravity to manufacture new or more effective therapeutics. This first-of-its-kind program leverages the extreme conditions of space to not only drive innovation but to build viable businesses at the intersection of commercial space and biomedical science.  

For over a decade, Life Science Nation (LSN) has connected entrepreneurs with early-stage capital and licensing via events, products, and services designed specifically for them, and this program is offering a great opportunity for well-matched startups. 

Description: A challenge to find novel solutions and technologies that support human health in space and/or are manufactured in space to support health on Earth. Challenge winners (8-10 companies) will participate in a 13-week program culminating with a Demo Day.

Focus areas: Biological and technological solutions that support our ability to live in and travel long distances through space; from regenerative medicine (cellular protection & repair, radiation & aging research, stem cell therapy, 3D bioprinting) to pharma (drug discovery and manufacturing) to synthetic bio (new medicines, modified foods, gene therapy, nutritional therapy) to wearables (health monitoring, medical devices, AI assisted diagnosis) to precision medicine (big data, genomics, AI/ML).

Who should apply: Global pre-seed and seed stage companies

Terms: The winning teams will receive $100,000+ each in prize funding and on-orbit research support, in exchange for equity.

Key dates:

  • Applications: April 18 – June 17
  • CIS Challenge Pitch Day: July 28
  • Program dates: September 12 – December 9
  • Demo Day: December 8

The program is looking for solutions with space and terrestrial application, with strong scientific merit, business model viability, and overall feasibility. If you believe your technology could be viable for the Care in Space program, follow this link to apply.

Digital Fatigue and the Future of Partnering

19 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

It will take decades to understand the full impact of the past couple years on the healthcare industry. These impacts range from public health adherence to treatments and even the rate of pharmaceutical development. However, beyond the obvious healthcare impacts are those that change how we work, interact, and communicate regularly. All these changes point to a need for connectivity, but also flexibility. Digital partnering has been a lifeline to many startups during the pandemic – building roads into networks of capital and licensing partners. However, as we move back into in-person partnering, the question remains is there a place for digital partnering in the future?

At Life Science Nation (LSN), we frequently source feedback from our clients and community. Surveys, one-on-one interviews, and conversations provide valuable insight into how market shifts have a real impact on the RESI network. We hear from the startup founder who is strapped for cash, looking for ways to connect with well-matched investors and strategic partners. For these clients, digital partnering is a low-cost alternative to in-person events. We also hear from busy investors, for whom the pandemic has increased productivity in that they can pack their days with meetings all from the convenience of home. We’ve also heard from entrepreneurs who would prefer to use their partnering budget for an optimum in-person option, as well as investors who have told us that it’s the quality of the in-person meeting that makes the deal, not the number of meetings in a day.

Digital fatigue is real, but it’s more complicated and nuanced than a single process or platform. One cause of fatigue is likely linked to the excess time and resources it takes to learn new systems and optimize them, not to mention the frustration that comes with knowing there aren’t other options available. We are now met with more options in the form of digital, in-person, and various forms of hybrid events. Going forward, it’s the goal of RESI to always offer attendees opportunities to connect with the partners who will join them along the way to their next milestone. This may take new forms but will prioritize both digital and in-person events to accommodate the unique needs of the early-stage ecosystem. As we look forward to our upcoming digital and in-person events, we hope to hear from our community how we can best support their efforts in continuing the important work they do to reshape the landscape of healthcare.

Digital RESI returns June 7-9 and may be the last chance before the summer breaks to connect with potential partners who are a fit for your product and stage of development. Participating in Digital RESI June could launch the second half of your 2022 global partnering campaign, with an in-person RESI September, Digital RESI November, and RESI JPM to round out the calendar. If you’d like an inside look at investors who are signed up who may be a fit for your needs or have questions about the digital format or your marketing collateral, contact us and we’d be happy to help!

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Alex
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Alexander Vassallo
Manager of Business Development
Book a Meeting
Email Me

The Global Entrepreneurial Classroom

19 May

By Alexander Vassallo, Manager of Business Development West Coast (US), LSN

Launching and successfully growing a life science company is an extremely challenging endeavor, but if done successfully, can foster new paradigms of healthcare and lead to healthier lives for individuals around the globe. It is for this reason that Life Science Nation (LSN), the industry leader in connecting early-stage life science firms with capital investors and strategic partners, has developed a series of new educational courses, ranging from half a day to three days, for aspiring scientist-entrepreneurs and fundraising executives.

Launching and Funding Startups: Seed to Series B is a free half-day course designed to introduce early-stage life science executives to the tools and tips they will need to successfully launch a company and begin to interact with your target partners and investors. The course will cover several fundamental entrepreneurial concepts such as how to perform entrepreneurial due diligence, branding and messaging and the importance of telling a cogent company story through multiple modalities, and the 10 myths of fundraising. This course can be complemented by an optional afternoon session (bringing the course to a full day) where LSN staff will work directly with companies to help review their non-confidential materials, perform a competitive landscape analysis, and generate a global target list of investors.

Mapping the Landscape of Strategic Partners for Your Startup is a paid one-day course for fundraising executives who have launched an early-stage life science firm and will actively be seeking partners for capital (Seed to Series B), joint product collaboration, or licensing distribution deals. The course will cover a tactical to-do list for the early-stage entrepreneur and participants will be equipped with the skills and tools necessary to successfully undertake a global fundraising campaign. The course will finish with a Tales from the Road (TFTR) panel that will involve seasoned entrepreneurs in the LSN network sharing their experiences of their fundraising journeys and launching life science companies. The price of this course is $1,400 per company and includes two spots per company (one business and one science executive).

Preparing for Your Global Fundraising Roadshow is a paid two-day course that will cover an extensive dive into developing a professional set of marketing, non-confidential materials that the early-stage life science executive can bring to any investor meeting and partnering conference during their fundraising campaign: tagline, elevator pitch, executive summary, one-page data sheet, and pitch deck. Participants will also be taught how to research global investors, collaborators, and licensing partners who are a right fit for your company’s technology and stage of development and how to interact with your target partners. A third day of early-stage life science strategics can be added to the course (bringing it to a full three days) to further prepare participants for their fundraising journeys. Navigating the pitfalls that commonly catch first-time CEOs off-guard, creating a network of global alliances through social and business media, and mapping the competitive global landscape to elucidate the value of your startup are important themes that will be covered. The three-day version of the Preparing for Your Global Fundraising Roadshow course will conclude with a live Shark Tank to active investor judges. The price of the two-day course is $3,500, and the price of the three-day course is $4,500, with two spots per company for each course (one business and one science executive).

If you’re interested in learning more and participating in a course, please feel free to reach out to Alexander Vassallo at a.vassallo@lifesciencenation.com to schedule a call and explore the new range of LSN entrepreneurial education courses.

Crafting the Perfect Message

19 May

By Karen Deyo, Director of Investor Research, Israel BD, LSN

You’ve registered for a partnering conference.

You’ve filled out a profile in the partnering system detailing who you are and what your company does.

You’ve researched the investors in attendance and built a list of targets to book meetings with.

You hit “Send Message” and freeze.

What do you say?

Partnering is an involved process with multiple steps that must be taken to ensure optimal results. These steps often require major time investment, and we forget that, even after the hours we’ve poured into the process, none of it matters without a compelling message to pique the interest of a potential partner.

Life Science Nation (LSN) has developed and consolidated the messaging process into easy steps:

  1. Introduction: The first message is the one where you introduce yourself and your company, as well as request a meeting. It’s ok if your target investor does not respond immediately (hence this system). To help them understand your position, it’s important to include the following:
    1. Company tagline (5-6 words explaining who you are and what you do)
    2. Elevator pitch (1-3 sentences describing the company and tech)
    3. Technology differentiation, product innovation, or market position
    4. Raise and milestone information
  2. Follow Up 1 (Product/Tech): Why is your product and technology unique? Is it first-in-class? Best-in-class? This is your opportunity to dive into your company’s differentiated value.
  3. Follow Up 2 (Management/Team): Highlight your management and team. How have your people had a notable impact on the business development? What makes your people special?
  4. Follow Up 3 (One Pager): Condense all the important messages you’ve already shared into a one-page tear sheet for quick and easy reference later. Even if the investor you’ve targeted is not a fit, this will make it easier for them to share your company with another.

It should go without saying that the perfect message is meaningless without a well-researched and formulated target list and marketing collateral at the ready. Think of the perfect message like how an athlete approaches the arena on game day. It’s the starting shot of a long and exciting process. It won’t replace the training and conditioning that got you to game day, but it’ll ensure you’re off with a competitive edge.

Partnering is open for Digital RESI, June 7-9 and there is still time to register! Contact us to see which investors are currently active in our partnering system who may be a fit for you.

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Alex
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Alexander Vassallo
Manager of Business Development
Book a Meeting
Email Me

Selling, Cold Calling, and Follow-Up Are Not Dirty Words

13 May

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

The coaching and mentoring universe is divided between those who think that selling, cold calling, and follow-ups are dirty words. They’re likely to proselytize that if you do not have a warm referral, you are wasting your time. The other camp (where I live) supports finding partners based on the fit of product and stage of development and reaching out until you book that meeting or are told, “No.” Life Science Nation created the RESI conference to be a vehicle to make this happen, based on fit – the other “warm referral.”

Opportunity abounds in the golden age of life science with new tools and technologies adding to the dynamic, but we’re also seeing startups fail faster, and therefore pivot, restart, and draw a straighter line to viable targets and products. I hear frequently that the magic combination is being smart and lucky, but somewhere in the middle of being smart and lucky is determination, commitment to hard, tedious work, and navigating the path to a new product. This is the case for founders taking their companies from regional to global and finding investors and licensing partners that are a fit.

RESI is a conference designed for these entrepreneurs to flourish. It’s frustrating to see partnering events with little vetted investors or licensing partners, but rather services providers wanting to charge for their partnering services. These other partnering events are more of a social gathering for reconnecting business acquaintances, which makes it a challenge in choosing the right event for you. None of this is inherently wrong, but the current need is for real vetted partners who are looking to fulfil investment mandates and product pipelines.

The early-stage marketplace is heating up with growing buy-side players seeking these startups. Join us for Digital RESI, June 7-9 and mark your calendar for the first in-person RESI since 2020 – RESI Boston, September 21-22.

← Older Entries
Newer Entries →